Therapeutic Asset Ratings
3,187 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cd70-targeting car-t cells
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
cd70-targeting car-t cells
Cervical Cancer
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
cd70-targeting car-t cells
Metastatic Neoplasm
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Juvenile Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Acute Biphenotypic Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
CD4+/CD56+ Hematodermic Neoplasm
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Childhood Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Chronic Myeloid Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr
Adult Acute Lymphoblastic Leukemia
Fred Hutchinson Cancer Center
P1
CC
(43)
Cea Car-T Cells
Metastatic Neoplasm
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Cea Car-T Cells
Cancer
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Cea-Targeted Car-T
Bile Duct Cancer
Chongqing Precision Biotech Co., Ltd
P1
CC
(43)
Cea-Targeted Car-T
Peritoneal Carcinomatosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Chimeric Antigen Receptor Modified T Cells Infusion
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nelson Hamerschlak
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Malignant Glioma
City of Hope Medical Center
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade II Glioma
City of Hope Medical Center
P1
CC
(43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade III Glioma
City of Hope Medical Center
P1
CC
(43)
Chm-1101 Car-T Cells
Brain Glioblastoma
Chimeric Therapeutics
P1
CC
(43)
cht101
Cervical Cancer
Zhejiang University
P1
CC
(43)
cht101
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and Hospital
P1
CC
(43)
Showing 1276 to 1300 of 3,187 assets
Previous
Page 52 of 128
Next